1. Home
  2. ALT vs SNDL Comparison

ALT vs SNDL Comparison

Compare ALT & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • SNDL
  • Stock Information
  • Founded
  • ALT 1997
  • SNDL 2006
  • Country
  • ALT United States
  • SNDL Canada
  • Employees
  • ALT N/A
  • SNDL N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • SNDL Pharmaceuticals and Biotechnology
  • Sector
  • ALT Health Care
  • SNDL Health Care
  • Exchange
  • ALT Nasdaq
  • SNDL Nasdaq
  • Market Cap
  • ALT 397.4M
  • SNDL 319.0M
  • IPO Year
  • ALT N/A
  • SNDL 2019
  • Fundamental
  • Price
  • ALT $4.16
  • SNDL $1.51
  • Analyst Decision
  • ALT Strong Buy
  • SNDL Buy
  • Analyst Count
  • ALT 6
  • SNDL 1
  • Target Price
  • ALT $18.20
  • SNDL $3.25
  • AVG Volume (30 Days)
  • ALT 11.4M
  • SNDL 2.1M
  • Earning Date
  • ALT 08-07-2025
  • SNDL 07-31-2025
  • Dividend Yield
  • ALT N/A
  • SNDL N/A
  • EPS Growth
  • ALT N/A
  • SNDL N/A
  • EPS
  • ALT N/A
  • SNDL N/A
  • Revenue
  • ALT $20,000.00
  • SNDL $645,362,646.00
  • Revenue This Year
  • ALT N/A
  • SNDL $4.70
  • Revenue Next Year
  • ALT $1,557,547.90
  • SNDL $3.87
  • P/E Ratio
  • ALT N/A
  • SNDL N/A
  • Revenue Growth
  • ALT N/A
  • SNDL 1.30
  • 52 Week Low
  • ALT $2.90
  • SNDL $1.15
  • 52 Week High
  • ALT $11.16
  • SNDL $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ALT 40.54
  • SNDL 70.99
  • Support Level
  • ALT $4.07
  • SNDL $1.36
  • Resistance Level
  • ALT $4.79
  • SNDL $1.64
  • Average True Range (ATR)
  • ALT 0.45
  • SNDL 0.07
  • MACD
  • ALT -0.10
  • SNDL 0.04
  • Stochastic Oscillator
  • ALT 28.16
  • SNDL 82.65

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

Share on Social Networks: